United States was Sensus Healthcare’s largest region in fiscal 2025, bringing in $25.36M of $27.48M (92%).
| Geography | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| United States | $41.98M | $22.28M | $40.18M | $25.36M |
| China | $2.45M | $1.49M | $1.45M | $2.03M |
| Türkiye | — | $265.00K | — | — |
| Guatemala | — | $190.00K | — | — |
| Ireland | — | $135.00K | — | — |
| Other | $104.00K | $2.00K | $182.00K | $90.00K |
| Israel | — | $43.00K | — | — |
| Total | $44.53M | $24.41M | $41.81M | $27.48M |
Sensus Healthcare brought in $27.48M from its three regions in fiscal 2025, the year ended December 31, 2025. That was down 34.3% from $41.81M in fiscal 2024. United States was the largest at $25.36M (92.3%), ahead of China at $2.03M (7.4%) and Other at $90.00K (0.3%).
Compared with fiscal 2024, China grew 40.5% to $2.03M, while United States fell 36.9% to $25.36M. From fiscal 2022 to 2025, combined revenue from these regions fell from $44.53M to $27.48M, a compound annual decline of 14.9%. United States' share of the total fell from 94.3% to 92.3%.
Sensus Healthcare stopped reporting Türkiye ($265.00K in fiscal 2023), Guatemala ($190.00K in fiscal 2023), Ireland ($135.00K in fiscal 2023) and one other as separate regions.
Product was Sensus Healthcare’s largest product and service line in fiscal 2025, bringing in $19.76M of $27.48M (72%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Product | — | $20.35M | $36.40M | $19.76M | |||||
| Product Revenue - Recognized At A Point In Time | $40.01M | — | — | — | |||||
| Service Revenue | — | $2.80M | $3.20M | $3.46M | |||||
| Service Revenue - Recognized Over Time | $3.17M | — | — | — | |||||
| Service | — | $1.26M | $1.96M | $2.54M | |||||
| Service Revenue - Recognized At A Point In Time | $1.35M | — | — | — | |||||
| Product Revenue | — | — | $247.00K | $1.72M | |||||
| Total | $44.53M | $24.41M | $41.81M | $27.48M |
Sensus Healthcare brought in $27.48M from its four product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 34.3% from $41.81M in fiscal 2024. Product was the largest at $19.76M (71.9%), ahead of Service Revenue at $3.46M (12.6%) and Service at $2.54M (9.2%). The remaining line, Product Revenue, brought in $1.72M.
Compared with fiscal 2024, Product Revenue grew fastest, up 596.8% to $1.72M, while Product fell the most, down 45.7% to $19.76M.
Sensus Healthcare stopped reporting Product Revenue - Recognized At A Point In Time ($40.01M in fiscal 2022), Service Revenue - Recognized Over Time ($3.17M in fiscal 2022) and Service Revenue - Recognized At A Point In Time ($1.35M in fiscal 2022) as separate lines.
Sensus Healthcare (SRTS) reports its revenue by geography and by product and service. In fiscal 2025, United States was its largest region, bringing in $25.36M (92.3% of the total), followed by China at $2.03M (7.4%).
United States was Sensus Healthcare's largest region in fiscal 2025, bringing in $25.36M, or 92.3% of the $27.48M total across its three regions.
Product was Sensus Healthcare's largest product and service line in fiscal 2025, bringing in $19.76M, or 71.9% of the $27.48M total across its four product and service lines.
China grew faster than United States in fiscal 2025, up 40.5% from $1.45M to $2.03M. United States fell 36.9% to $25.36M.
Every figure comes from Sensus Healthcare's annual financial filings, as reported. Each line keeps the name Sensus Healthcare gives it, and years follow its fiscal calendar.
Sensus Healthcare's revenue by geography goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.